Stella Diagnostics Inc. (SLDX)

USD 0.04

(0.0%)

Total Liabilities Summary of Stella Diagnostics Inc.

  • Stella Diagnostics Inc.'s latest annual total liabilities in 2023 was 18 Million USD , down -18.33% from previous year.
  • Stella Diagnostics Inc.'s latest quarterly total liabilities in 2024 Q2 was 18.41 Million USD , up 3.05% from previous quarter.
  • Stella Diagnostics Inc. reported annual total liabilities of 22.04 Million USD in 2022, down -89.67% from previous year.
  • Stella Diagnostics Inc. reported annual total liabilities of 213.46 Million USD in 2021, up 1916.65% from previous year.
  • Stella Diagnostics Inc. reported quarterly total liabilities of 17.87 Million USD for 2024 Q1, down -0.74% from previous quarter.
  • Stella Diagnostics Inc. reported quarterly total liabilities of 18 Million USD for 2023 Q4, up 6.77% from previous quarter.

Annual Total Liabilities Chart of Stella Diagnostics Inc. (2023 - 2013)

Historical Annual Total Liabilities of Stella Diagnostics Inc. (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 18 Million USD -18.33%
2022 22.04 Million USD -89.67%
2021 213.46 Million USD 1916.65%
2020 10.58 Million USD 70.37%
2019 6.21 Million USD 20.62%
2018 5.15 Million USD 208.62%
2017 1.66 Million USD 0.0%
2015 1.51 Million USD 0.08%
2014 1.51 Million USD 115737.16%
2013 1306.86 USD 0.0%

Peer Total Liabilities Comparison of Stella Diagnostics Inc.

Name Total Liabilities Total Liabilities Difference
American Bio Medica Corporation 3.6 Million USD -399.041%
Arrayit Corporation 7.49 Million USD -140.181%
Atlantic International Corp. 3.82 Million USD -370.285%
Biocept, Inc. 22.01 Million USD 18.206%
Bioqual, Inc. 18.93 Million USD 4.924%
CardioGenics Holdings Inc 1.79 Million USD -903.13%
DermTech, Inc. 64.75 Million USD 72.195%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 734.97 Million USD 97.55%
HTG Molecular Diagnostics, Inc. 12.38 Million USD -45.369%
iMD Companies, Inc. 1.67 Million USD -975.453%
IDenta Corp. 1.01 Million USD -1677.157%
Interpace Biosciences, Inc. 28.15 Million USD 36.054%
Integrative Health Technologies, Inc. 297.94 Thousand USD -5943.157%
InVitro International 78.99 Thousand USD -22694.537%
Lumos Diagnostics Holdings Limited 19.72 Million USD 8.736%
Many Bright Ideas Technologies Inc. 129.29 Thousand USD -13825.617%
Medical Imaging Corp. 9.51 Million USD -89.19%
NovelStem International Corp. 4.2 Million USD -328.081%
Optigenex Inc. 9.57 Million USD -88.132%
PharmChem, Inc. 558.64 Thousand USD -3123.038%
Proteome Sciences plc 18.48 Million USD 2.616%
Response Genetics, Inc 15.86 Million USD -13.477%
Rennova Health, Inc. 49.66 Million USD 63.748%
RushNet, Inc. 6.23 Million USD -188.595%
ScreenPro Security Inc. 1.6 Million USD -1024.925%
StageZero Life Sciences Ltd. 8.2 Million USD -119.471%
Todos Medical Ltd. 50.15 Million USD 64.102%